| |
| • |
DES
for Bifurcation Lesion |
| |
- Presenter: Yean-Teng Lim, MD |
| |
| • |
DES
for Complex Patients Subsets |
| |
- Presenter: Alexandre Abizaid, MD |
| |
| • |
Everolimus
Drug-Eluting Stents I: Review of Guidant FUTURE I and
II, and Status Update of FUTURE III and IV |
| |
- Presenter: Eberhard Grube, MD |
| |
| • |
ZoMaxx:
Abbott's Drug Eluting Stent Program |
| |
- Presenter: John Ormiston, MD |
| |
| • |
Drug-Eluting
Biodegradable Igaki-Tamai Stent |
| |
- Presenter: Hideo Tamai, MD |
| |
| • |
Update
on the Endeavor I-V Trials: The Latest Results |
| |
- Presenter: Ian T. Meredith, MD |
| |
| • |
Terumo
DES Program -Nobori 1 Clinical Trial |
| |
- Presenter: Hidehiko Honda, MD |
| |
| • |
Update
on Jupiter l and ll Clinical Trials with the Sorin Carbostent
Tacrocimus Eluting Stent |
| |
- Presenter: Gian Battista Danzi, MD |
| |
| • |
ABT
578 Drug-Eluting Stents II: Preclinical Observations
and the Clinical Trial Strategy for the Abbott ZoMax
Stent |
| |
- Presenter: Alan C. Yeung, MD |
| |
| • |
Reopro
Eluting Stents in Acute Coronary Syndrome |
| |
- Presenter: Myung-Ho Jeong, MD |
| |
| • |
Cypher
PK study in Japan |
| |
- Presenter: Masato Nakamura, MD |